Vial Dedicated Phase I Unit
Vial’s Dermatology Phase 1 unit provides a unified full service solution to early clinical development.
500+
Dermatology Clinical Trials
64
Phase 1 Studies
42
Indications
10,000+
Randomized Patients
Team
Phase 1 Units are critical to advancing care and validating treatments, that’s why it’s critical to have a Phase 1 Unit that you can rely on
Capabilities
Confinement, Repeat PKs, ECG, and other timed procedures by experienced staff who can handle the complexity of overlapping subjects with multiple repeat procedures
Our Phase 1 research coordinators are IATA and CPR certified with 5-25 year of experience! They are familiar with multiple EDS and IWRS systems. All research coordinators complete annual GCP and NIH training as well as in-house reucurring training.

DRI’s 7,000 sq ft clinic
- 7 exam rooms
- 2 labs
- 2 refrigerated centrifuges
- 2 commercial refrigerators for drug storage
- Dedicated photography room
- Large conference room
- Private monitoring offices with WiFi
- 350 sq.ft. secure, limited entry, temperature-controlled drug room
- Two minus 80 and three minus 20 freezers
- Extensive experience in FIH studies
- 16 dedicated beds (scale to 20)
- Full confinement capabilities
- Recreational areas, private rooms, full kitchen / showers
- Over 50 FIH/ PK studies completed
- Access to local laboratory
Case Study
One-site Phase 1 Actinic Keratosis study
One-site Phase 1 study initiated in February 2020 for Actinic Keratosis. Screened 48 and randomized 32 over a four month screening/ enrollment period. Study included multiple PK days (-1, -0.5, 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10 hrs) and overnight confinement. $15k ad budget.

